D
STAAR Surgical Company STAA
$18.03 $0.150.84% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/27/2024 09/27/2024 06/28/2024 03/29/2024 12/29/2023
Net Income -20.21M 21.78M 16.61M 15.30M 21.35M
Total Depreciation and Amortization 6.89M 5.73M 5.31M 5.24M 5.12M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 34.44M 30.08M 29.46M 30.56M 28.96M
Change in Net Operating Assets -5.40M -10.53M -14.12M -9.73M -40.84M
Cash from Operations 15.73M 47.05M 37.26M 41.37M 14.59M
Capital Expenditure -23.39M -20.76M -23.71M -20.49M -18.19M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -35.82M 3.44M 73.47M 101.09M 92.54M
Cash from Investing -59.22M -17.32M 49.76M 80.60M 74.35M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -165.00K -164.00K -161.00K -159.00K -161.00K
Issuance of Common Stock 7.39M 7.76M 13.36M 14.47M 9.67M
Repurchase of Common Stock -1.51M -1.40M -1.51M -1.48M -2.10M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 5.72M 6.20M 11.69M 12.83M 7.42M
Foreign Exchange rate Adjustments -1.11M 638.00K -634.00K -745.00K 202.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -38.88M 36.57M 98.08M 134.06M 96.56M